Cyclophosphamide 50 mg
$60.00 – $162.00Price range: $60.00 through $162.00
|
Cyclophosphamide 50 mg
|
Variation | Price | Price / Unit | Quantity | Add To Cart |
|---|---|---|---|---|
| 30 Tablet/s | $60.00 | $2/ Piece | ||
| 60 Tablet/s | $114.00 | $1.9/ Piece | ||
| 90 Tablet/s | $162.00 | $1.8/ Piece | ||
Description
Cyclophosphamide is a medication primarily used in the treatment of various types of cancer, including leukemia, lymphoma, multiple myeloma, and certain solid tumors. It belongs to a class of drugs known as alkylating agents, which work by interfering with the DNA in cancer cells, ultimately leading to their death. Cyclophosphamide is also used in the treatment of certain autoimmune diseases, such as rheumatoid arthritis and lupus, by suppressing the activity of the immune system. It is typically administered intravenously or taken orally.
| Active Ingredient (Generic Name): | Cyclophosphamide |
| Manufacturer: |
Zydus Lifesciences
|
| Packaging: | 10 Tablets in strip |
| Strength: | 50 mg |
| Delivery Time: | 6 To 15 days |
| SKU: | Cyclophosphamide 50 mg |
Additional information
| Quantity Value | 30 Tablet/s, 60 Tablet/s, 90 Tablet/s |
|---|
Be the first to review “Cyclophosphamide 50 mg” Cancel reply
You must be logged in to post a review.
Related products
-

Flutamide 250 mg
0 out of 5$75.00 – $180.00Price range: $75.00 through $180.00 Select options This product has multiple variants. The options may be chosen on the product page -

Lenalidomide 15 mg
0 out of 5$210.00 – $608.00Price range: $210.00 through $608.00 Select options This product has multiple variants. The options may be chosen on the product page -

Enzalutamide 40 mg
0 out of 5$280.00 – $756.00Price range: $280.00 through $756.00 Select options This product has multiple variants. The options may be chosen on the product page -

Bicalutamide 50 mg
0 out of 5$90.00 – $225.00Price range: $90.00 through $225.00 Select options This product has multiple variants. The options may be chosen on the product page

Reviews
There are no reviews yet.